SciTechDaily
New research reveals that semaglutide significantly improves liver health in MASH patients. A new study published in the New England Journal of Medicine reveals that semaglutide significantly improves outcomes for patients with a serious form of liver disease, benefiting approximately two-thirds of those treated. The findings come from the ESSENCE phase 3 clinical trial…
Read More
Reversing Liver Disease? Scientists Discover New Health Benefit of Semaglutide
09:30
New research reveals that semaglutide significantly improves liver health in MASH patients. A new study published in the New England Journal of Medicine reveals that semaglutide significantly improves outcomes for patients with a serious form of liver disease, benefiting approximately two-thirds of those treated. The findings come from the ESSENCE phase 3 clinical trial…
